Pfenex (PFNX) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free PFNX Stock Alerts $12.75 0.00 (0.00%) (As of 10/1/2020) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineNKY Medical Holdings Ltd Class A 300109morningstar.com - January 31 at 6:39 PMLigand Pharmaceuticals: Struggling Along (NASDAQ:LGND) - Seeking Alphaseekingalpha.com - September 25 at 12:22 PMForte Biosciences, Inc. Announces Second Quarter 2022 Results and Provides Business Update - Business Wirebusinesswire.com - August 15 at 7:25 PMLigand Reports Second Quarter 2022 Financial Results - Business Wirebusinesswire.com - August 9 at 3:15 AM2022-08-08 | NDAQ:LGND | Press Release | Ligand Pharmaceuticals Incorporated - Stockhousestockhouse.com - August 8 at 5:13 PMOsteoporosis Therapeutics Market to Top US$ 14 Bn Valuation by 2026: Fact.MR Analysis - Yahoo Financefinance.yahoo.com - May 17 at 4:42 PMLigand Reports First Quarter 2022 Financial Results - StreetInsider.comstreetinsider.com - May 5 at 1:18 AMLigand Reports First Quarter 2022 Financial Results - Marketscreener.commarketscreener.com - May 4 at 8:18 PMLigand Pharmaceuticals: Moving Parts Keep Moving - Seeking Alphaseekingalpha.com - March 29 at 3:05 AMGlobal Pharma, Biotech and Diagnostics Joint Venture Partnering Deal Terms and Agreements Analysis Report 2021 with Example Case Studies of Agila Specialties/Pfenex and Dance Biopharm/Harmony Asset - PR Newswireprnewswire.com - March 24 at 12:22 PMLigand Reports Fourth Quarter and Full Year 2021 Financial Results - Business Wirebusinesswire.com - February 17 at 5:39 PMPipeline Therapeutics Appoints Eef Schimmelpennink to its Board of Directors - Business Wirebusinesswire.com - February 15 at 8:41 AMLIGAND PHARMACEUTICALS INC : Termination of a Material Definitive Agreement (form 8-K) - marketscreener.commarketscreener.com - January 14 at 6:21 PMDr. Hubert Chen Joins ADARx Pharmaceuticals as Chief Medical Officer - Business Wirebusinesswire.com - January 5 at 7:31 AMSolid Nutrition Unit to Aid Archer Daniels (ADM) Amid Cost Woes - Nasdaqnasdaq.com - November 10 at 11:21 PMDare Bioscience, Inc. (DARE) Reports Q3 Loss, Lags Revenue Estimates - Nasdaqnasdaq.com - November 10 at 1:20 PMfuboTV Falls 7% Despite Solid Q3 Results - Nasdaqnasdaq.com - November 10 at 1:20 PMLIGAND PHARMACEUTICALS INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - marketscreener.commarketscreener.com - November 9 at 8:03 PMLigand Reports Third Quarter 2021 Financial Results - Business Wirebusinesswire.com - November 9 at 8:03 PMGlobal Joint Venture Partnering Deals Report/Directory 2021: Trends, Players and Financials 2014-2021 - B - Benzingabenzinga.com - September 23 at 6:07 PMOphthalmology Biosimilars Market Report 2028 | Size, Share, Growth, Trends, Competitive Landscape, Revenue, Forecast - Yahoo Financeyahoo.com - September 7 at 8:50 PMLigand Pharmaceuticals Incorporated (LGND) Q2 2021 Earnings Call Transcript - Motley Foolfool.com - July 30 at 9:31 AMLigand Reports Second Quarter 2021 Financial Results - Business Wirebusinesswire.com - July 29 at 6:46 PM Get Pfenex News Delivered to You Automatically Sign up to receive the latest news and ratings for PFNX and its competitors with MarketBeat's FREE daily newsletter. Email Address The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him PFNX Media Mentions By Week PFNX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PFNX News Sentiment▼0.000.44▲Average Medical News Sentiment PFNX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PFNX Articles This Week▼00▲PFNX Articles Average Week Get Pfenex News Delivered to You Automatically Sign up to receive the latest news and ratings for PFNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CYBN News NGM News KNTE News AVAH News TRDA News HUMA News STTK News TVTX News NVRO News FULC News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:PFNX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pfenex Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
